Short Interest in Aptorum Group Limited (NASDAQ:APM) Drops By 57.4%

Aptorum Group Limited (NASDAQ:APM) was the recipient of a significant drop in short interest during the month of January. As of January 15th, there was short interest totalling 78,800 shares, a drop of 57.4% from the December 31st total of 184,800 shares. Based on an average daily trading volume, of 2,220,000 shares, the short-interest ratio is presently 0.0 days. Currently, 2.0% of the shares of the stock are short sold.

Aptorum Group Trading Down 1.7 %

Shares of Aptorum Group stock traded down $0.02 on Friday, hitting $1.21. 96,474 shares of the company traded hands, compared to its average volume of 1,013,878. The business has a 50-day simple moving average of $1.11 and a 200 day simple moving average of $1.93. Aptorum Group has a 52 week low of $0.46 and a 52 week high of $17.49.

About Aptorum Group

Aptorum Group Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of infectious diseases and cancer. The company operates in the Therapeutics and Non-Therapeutics segments. Its pipeline products include SACT- 1 for neuroblastoma and other cancer types; SACT-COV19 for the treatment of coronavirus disease; ALS-4 to treat bacterial infections caused by staphylococcus aureus, including MRSA; and ALS-1 to treat viral infections caused by influenza virus A.